These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10529641)

  • 21. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of enalapril and losartan on mechanical ventilation-induced sympathoadrenal activation and oxidative stress in rats.
    Toklu HZ; Kwon OS; Sakarya Y; Powers SK; Llinas K; Kirichenko N; Sollanek KJ; Wiggs MP; Smuder AJ; Talbert EE; Scarpace PJ; Tümer N
    J Surg Res; 2014 May; 188(2):510-6. PubMed ID: 24630519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enalapril reduces the expression of nuclear factor-kappaB and c-Jun N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats.
    Costa JC; Costa RS; Silva CG; Coimbra TM
    Am J Nephrol; 2006; 26(3):281-6. PubMed ID: 16772709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin-angiotensin system inhibitors as antihypertrophic agents.
    Ianosi-Irimie M; Deutsch P
    Pharmazie; 2000 Aug; 55(8):629. PubMed ID: 10989849
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
    Jackson B; Franze L; Sumithran E; Johnston CI
    J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
    Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.
    Yang Z; Yu X; Cheng L; Miao LY; Li HX; Han LH; Jiang WP
    Arch Cardiovasc Dis; 2013 Apr; 106(4):196-201. PubMed ID: 23706365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F; Kuru O; Sentürk UK
    Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA; Calzada C; Ballesteros A; Amato D
    Rev Invest Clin; 2012; 64(4):315-21. PubMed ID: 23227581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M; Gross ML; Amann K; Ritz E
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enalapril attenuates ischaemic brain oedema and protects the blood-brain barrier in rats via an anti-oxidant action.
    Panahpour H; Dehghani GA; Bohlooli S
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):220-6. PubMed ID: 24471927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enalapril--an oral angiotensin-converting enzyme inhibitor: its pharmacological properties and clinical use].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1988 Feb; 43(9):279-83. PubMed ID: 2841654
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Domergue V; De Gasparo M; Giudicelli JF
    J Card Fail; 2001 Sep; 7(3):269-76. PubMed ID: 11561229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of enalapril on endotheliun-dependent contractile reactions and oxygen cost of work of the smooth muscles in experimental diabetes mellitus].
    Prysiazhna OD; Kotsiuruba AV; Tkachenko MM; Sahach VV
    Fiziol Zh (1994); 2007; 53(1):3-10. PubMed ID: 17500196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats.
    de Cavanagh EM; Piotrkowski B; Basso N; Stella I; Inserra F; Ferder L; Fraga CG
    FASEB J; 2003 Jun; 17(9):1096-8. PubMed ID: 12709417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.